LABS logo

MediPharm Labs Corp. Stock Price

TSX:LABS Community·CA$27.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

LABS Share Price Performance

CA$0.065
-0.01 (-7.14%)
CA$0.065
-0.01 (-7.14%)
Price CA$0.065

LABS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
2 Rewards

MediPharm Labs Corp. Key Details

CA$46.1m

Revenue

CA$32.1m

Cost of Revenue

CA$14.0m

Gross Profit

CA$22.0m

Other Expenses

-CA$8.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.019
30.28%
-17.41%
0.9%
View Full Analysis

About LABS

Founded
2015
Employees
161
CEO
David Pidduck
WebsiteView website
www.medipharmlabs.com

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.

Recent LABS News & Updates

Recent updates

No updates